These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33609917)

  • 21. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
    Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P
    Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
    Thakral S; Singh V
    Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel acyl hydrazide derivatives of polyhydroquinoline as potent anti-diabetic and anti-glycating agents: Synthesis, in vitro α-amylase, α-glucosidase inhibition and anti-glycating activity with molecular docking insights.
    Ur Rahman S; Alam A; Parveen Z; Zainab ; Assad M; Adnan Ali Shah S; Rafiq H; Ayaz M; Latif A; Naveed Umar M; Ali M; Ahmad M
    Bioorg Chem; 2024 Sep; 150():107501. PubMed ID: 38865858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
    Gong Z; Xie Z; Qiu J; Wang G
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
    Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
    Wang G; He D; Li X; Li J; Peng Z
    Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
    Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA
    Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celebrex derivatives: Synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies.
    Kausar N; Ullah S; Khan MA; Zafar H; Atia-Tul-Wahab ; Choudhary MI; Yousuf S
    Bioorg Chem; 2021 Jan; 106():104499. PubMed ID: 33288319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
    Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
    Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase.
    Özil M; Emirik M; Beldüz A; Ülker S
    Bioorg Med Chem; 2016 Nov; 24(21):5103-5114. PubMed ID: 27576293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
    Wang G; Peng Z; Gong Z; Li Y
    Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and α-glucosidase-inhibitory activity of phenoxy-biscoumarin-N-phenylacetamide hybrids.
    Ansari S; Azizian H; Pedrood K; Yavari A; Mojtabavi S; Faramarzi MA; Golshani S; Hosseini S; Biglar M; Larijani B; Rastegar H; Hamedifar H; Mohammadi-Khanaposhtani M; Mahdavi M
    Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100179. PubMed ID: 34467580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs.
    Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM
    Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of novel pyridazine N-aryl acetamides: In-vitro evaluation of α-glucosidase inhibition, docking, and kinetic studies.
    Moghimi S; Toolabi M; Salarinejad S; Firoozpour L; Sadat Ebrahimi SE; Safari F; Mojtabavi S; Faramarzi MA; Foroumadi A
    Bioorg Chem; 2020 Sep; 102():104071. PubMed ID: 32688112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.